These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27084254)

  • 61. Moving towards a new era in the management of chronic immune thrombocytopenia.
    Wadenvik H; Olsson B
    Ann Hematol; 2010 Jul; 89 Suppl 1():87-93. PubMed ID: 20339846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mental health and use of psychotropic prescription drugs in adult patients with primary immune thrombocytopenia: a nationwide population-based cohort study.
    Mannering N; Hansen DL; Pottegård A; Andersen K; Frederiksen H
    Haematologica; 2024 Sep; 109(9):2944-2954. PubMed ID: 38721747
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immune thrombocytopenia and risk of stroke: Evidence from a nationwide population-based cohort study.
    Chen HY; Lee WK; Chang R; Hung YM; Hsu CY; Shih YH; Chen JS
    Int J Stroke; 2023 Apr; 18(4):408-415. PubMed ID: 36073612
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.
    Kuter DJ; Bussel JB; Newland A; Baker RI; Lyons RM; Wasser J; Viallard JF; Macik G; Rummel M; Nie K; Jun S
    Br J Haematol; 2013 May; 161(3):411-23. PubMed ID: 23432528
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].
    López MF; Mingot ME; Valcárcel D; Vicente García V; Perrin A; Campos Tapias I
    Med Clin (Barc); 2015 May; 144(9):389-96. PubMed ID: 24565604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience.
    Pasquet M; Aladjidi N; Guiton C; Courcoux MF; Munzer M; Auvrignon A; Lutz P; Ducassou S; Leroy G; Munzer C; Leverger G;
    Br J Haematol; 2014 Jan; 164(2):266-71. PubMed ID: 24152194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.
    Mahévas M; Fain O; Ebbo M; Roudot-Thoraval F; Limal N; Khellaf M; Schleinitz N; Bierling P; Languille L; Godeau B; Michel M
    Br J Haematol; 2014 Jun; 165(6):865-9. PubMed ID: 24725224
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A retrospective observational single-centre study on the burden of immune thrombocytopenia (ITP).
    Bauer M; Baumann A; Berger K; Ackermann B; Shlaen R; Schopohl D; Ostermann H
    Onkologie; 2012; 35(6):342-8. PubMed ID: 22722454
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura.
    Dultz G; Kronenberger B; Azizi A; Mihm U; Vogl TJ; Sarrazin U; Sarrazin C; Zeuzem S; Hofmann WP
    J Hepatol; 2011 Jul; 55(1):229-32. PubMed ID: 21310200
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study.
    Nørgaard M; Jensen AØ; Engebjerg MC; Farkas DK; Thomsen RW; Cha S; Zhao S; Sørensen HT
    Blood; 2011 Mar; 117(13):3514-20. PubMed ID: 21263148
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics.
    Park HK; Lee SH
    Neurol Sci; 2014 Nov; 35(11):1801-6. PubMed ID: 24880747
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes in the Incidence of Immune Thrombocytopenia in the Coronavirus Disease 2019 Era: A Nationwide Observational Study in Korea.
    Choi YB; Jung HJ; Kim HR; Jeong SI
    Risk Manag Healthc Policy; 2023; 16():667-676. PubMed ID: 37064796
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database.
    Sarpatwari A; Bennett D; Logie JW; Shukla A; Beach KJ; Newland AC; Sanderson S; Provan D
    Haematologica; 2010 Jul; 95(7):1167-75. PubMed ID: 20145266
    [TBL] [Abstract][Full Text] [Related]  

  • 74. All-trans retinoic acid added to treatment of primary immune thrombocytopenia: a systematic review and meta-analysis.
    Yang J; Zhao L; Wang W; Wu Y
    Ann Hematol; 2023 Jul; 102(7):1695-1704. PubMed ID: 37166528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Incidence and Risk of Various Types of Arterial Thromboembolism in Patients With Cancer.
    Wang J; Kim YD; Kim CH
    Mayo Clin Proc; 2021 Mar; 96(3):592-600. PubMed ID: 33673912
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic immune thrombocytopenia in Denmark, Sweden and Norway: The Nordic Country Patient Registry for Romiplostim.
    Christiansen CF; Bahmanyar S; Ghanima W; Risbo N; Ekstrand C; Stryker S; Acquavella J; Kilpatrick K; Frederiksen H; Nørgaard M; Sørensen HT
    EClinicalMedicine; 2019 Sep; 14():80-87. PubMed ID: 31709405
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States.
    Lo Re Iii V; Cocoros NM; Hubbard RA; Dutcher SK; Newcomb CW; Connolly JG; Perez-Vilar S; Carbonari DM; Kempner ME; Hernández-Muñoz JJ; Petrone AB; Pishko AM; Rogers Driscoll ME; Brash JT; Burnett S; Cohet C; Dahl M; DeFor TA; Delmestri A; Djibo DA; Duarte-Salles T; Harrington LB; Kampman M; Kuntz JL; Kurz X; Mercadé-Besora N; Pawloski PA; Rijnbeek PR; Seager S; Steiner CA; Verhamme K; Wu F; Zhou Y; Burn E; Paterson JM; Prieto-Alhambra D
    Clin Epidemiol; 2024; 16():71-89. PubMed ID: 38357585
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence and Incidence of Immune Thrombocytopenia in Patients With Prostate Cancer.
    Vontela N; Kovesdy C; Latif Z; Lane R; Weir A
    Am J Med Sci; 2018 Nov; 356(5):499-500. PubMed ID: 30006195
    [No Abstract]   [Full Text] [Related]  

  • 79. Pulmonary Thromboembolism in Immune Thrombocytopenia: A Report of Five Cases and a Review of the Literature.
    Tan Y; Yan M; Cheng Z; Pan X
    Int J Gen Med; 2021; 14():4479-4483. PubMed ID: 34413675
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The epidemiology of immune thrombocytopenia.
    Schlech WF; Nesdoly C; Meagher N; Turner J; Dickey D
    Can J Infect Dis; 1992 Nov; 3(6):311-4. PubMed ID: 22346407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.